TEM
NASDAQ · Life Sciences Tools & Services
Tempus Ai Inc
$76.05
+5.62 (+7.98%)
Financial Highlights (FY 2026)
Revenue
1.23B
Net Income
-237,521,777
Gross Margin
62.7%
Profit Margin
-19.3%
Rev Growth
+58.3%
D/E Ratio
2.52
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 62.7% | 62.7% | 44.0% | 44.0% |
| Operating Margin | -20.8% | -18.7% | 20.9% | 23.7% |
| Profit Margin | -19.3% | -18.3% | 17.8% | 17.2% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 1.23B | 778.83M | 4.22B | 4.70B |
| Gross Profit | 773.47M | 488.64M | 1.85B | 2.07B |
| Operating Income | -256,794,847 | -146,007,557 | 880.21M | 1.12B |
| Net Income | -237,521,777 | -135,049,339 | 751.80M | 807.44M |
| Gross Margin | 62.7% | 62.7% | 44.0% | 44.0% |
| Operating Margin | -20.8% | -18.7% | 20.9% | 23.7% |
| Profit Margin | -19.3% | -18.3% | 17.8% | 17.2% |
| Rev Growth | +58.3% | +58.3% | +21.7% | +17.2% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 4.60B | 4.60B | 4.60B | 4.62B |
| Total Equity | 1.82B | 1.82B | 6.78B | 7.47B |
| D/E Ratio | 2.52 | 2.52 | 0.68 | 0.62 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -240,984,686 | -144,630,394 | 1.29B | 1.47B |
| Free Cash Flow | — | — | 351.34M | 441.08M |